Loading…
Held by equity mutual funds in 31 disclosed months, Sep 2012 to Mar 2015.
Ranbaxy Laboratories Ltd (Pharmaceuticals) was held by 9 active equity mutual funds in March 2015, ₹156 Cr in all (up 1 fund from Feb 2015). The largest position was UTI - Pharma & Healthcare Fund at 4.9% of its portfolio. During the month 1 fund entered and 0 exited. Funds have disclosed holding it since Sep 2012.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
How many equity funds held the company each month, and the value they held.